BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30041734)

  • 1. Utility of liver biopsy in the evaluation of pediatric total parenteral nutrition cholestasis.
    Buonpane CL; Ares GJ; Englert EG; Helenowski I; Cohran VC; Hunter CJ
    Am J Surg; 2018 Oct; 216(4):672-677. PubMed ID: 30041734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral nutrition-associated cholestasis.
    Teitelbaum DH
    Curr Opin Pediatr; 1997 Jun; 9(3):270-5. PubMed ID: 9229168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation.
    Moss RL; Das JB; Raffensperger JG
    J Pediatr Surg; 1993 Oct; 28(10):1270-4; discussion 1274-5. PubMed ID: 8263685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
    Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
    Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total parenteral nutrition-associated cholestasis in infants: clinical and liver histologic studies.
    Chou YH; Yau KI; Hsu HC; Chang MH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(4):264-71. PubMed ID: 8213156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrotizing enterocolitis and total parenteral nutrition-associated cholestasis.
    Moss RL; Das JB; Raffensperger JG
    Nutrition; 1996 May; 12(5):340-3. PubMed ID: 8875518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.
    Mangalat N; Bell C; Graves A; Imseis EM
    BMC Pediatr; 2014 Dec; 14():298. PubMed ID: 25492029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital does not prevent total parenteral nutrition-associated cholestasis in noninfected neonates.
    Gleghorn EE; Merritt RJ; Subramanian N; Ramos A
    JPEN J Parenter Enteral Nutr; 1986; 10(3):282-3. PubMed ID: 3086586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
    Spagnuolo MI; Iorio R; Vegnente A; Guarino A
    Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
    Garzón L; Ledo A; Cubells E; Sáenz P; Vento M
    An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
    Arslanoglu S; Moro GE; Tauschel HD; Boehm G
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):228-31. PubMed ID: 18223390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine growth restriction impacts tolerance to total parenteral nutrition in extremely low birth weight infants.
    Baserga MC; Sola A
    J Perinatol; 2004 Aug; 24(8):476-81. PubMed ID: 15141267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
    Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease.
    Tsai S; Strouse PJ; Drongowski RA; Islam S; Teitelbaum DH
    J Pediatr Surg; 2005 Jan; 40(1):263-7. PubMed ID: 15868595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
    De Marco G; Sordino D; Bruzzese E; Di Caro S; Mambretti D; Tramontano A; Colombo C; Simoni P; Guarino A
    Aliment Pharmacol Ther; 2006 Jul; 24(2):387-94. PubMed ID: 16842466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment.
    Levine A; Maayan A; Shamir R; Dinari G; Sulkes J; Sirotta L
    J Pediatr Endocrinol Metab; 1999; 12(4):549-53. PubMed ID: 10417972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
    Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using volume index and lateral hepatic angle to differentiate biliary atresia from TPN-associated cholestasis.
    Peng SS; Hsu WM; Chen HL; Mo YH
    J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):403-8. PubMed ID: 24821537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestasis associated with total parenteral nutrition.
    Merritt RJ
    J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):9-22. PubMed ID: 3080580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.